4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-052411
Director sold 8,500 shares at an average $520.96 ($4,428,198)
- Director acquired 8,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levy Richard S Director | 2025-11-13 | Option exercise 10b5-1 | +2,500 | $7.36 | $18,400 | 23,697 | D |
| Levy Richard S Director | 2025-11-13 | Option exercise 10b5-1 | +6,000 | $16.46 | $98,760 | 29,697 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −146 | $514.67 | $75,142 | 29,551 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −919 | $515.64 | $473,876 | 28,632 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −645 | $517.51 | $333,796 | 27,987 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −835 | $518.53 | $432,974 | 27,152 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −1,355 | $519.67 | $704,147 | 25,797 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −308 | $520.68 | $160,369 | 25,489 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −1,094 | $521.79 | $570,836 | 24,395 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −1,434 | $522.70 | $749,557 | 22,961 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −811 | $523.66 | $424,687 | 22,150 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −153 | $524.49 | $80,247 | 21,997 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −120 | $526.68 | $63,202 | 21,877 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −200 | $527.85 | $105,570 | 21,677 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −440 | $528.60 | $232,586 | 21,237 | D |
| Levy Richard S Director | 2025-11-13 | Sale 10b5-1 | −40 | $530.21 | $21,208 | 21,197 | D |
| Derivatives | |||||||
| Levy Richard S Director | 2025-11-13 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,500 | 2,500 | D | ||
| Levy Richard S Director | 2025-11-13 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,000 | 4,000 | D | ||
| Open-market sales · 8,500 sh · avg $520.96 · $4,428,198 | |||||||
Loading xslF345X05/wk-form4_1763158342.xml…